ACR ITE 2002 Answers
6. D
7. B
8. C
9. E
10. B
11. T
12. F Often
13. F Lateral
14. T
15. T
16. F Also, RhA, enteropathic, gout, CPPD
17. F Similar to AS
18. F Synovial portion first
19. T
20. T
21. T
22. T
23. F Metatarsal
24. F Instability
25. T
26. F Lesser
27. F Degenerative
28. F
29. F Subscapularis
30. T
31. F Avulsion
32. F ?
33. T
34. F Expansion of canal
35. T
36. F Rarely
37. T
38. T
39. F Epiphyseal
40. F Due to expansion
41. F Well recognized
42. T
43. T
44. T
45. F Common
46. F Poorly mineralised osteoid
47. T
48. T
49. F Only secondary
50. T
51. E
52. A
53. B
54. E
55. D
56. T
57. F
58. F
59. T
60. T
61. F
62. T
63. T
64. T
65. T
66. T
67. F
68. F
69. T
70. F
71. T
72. T
73. T
74. F
75. T
76. T
77. F
78. T
79. F
80. F
81. F
82. T
83., T
84. T
85. T
86. F
87. T
88. T
89. F
90. F
91. F
92. T
93. T
94. T
95. T
96. C
97. A
98. C
99. B
100. NS
101. F
102. T
103. T
104. T
105. F
106. F
107. T
108. T
109. T
110. F
111. F
112. T
113. T
114. T
115. F
116. T
117. F
118. F
119. F
120. F
121. T
122. T
123. T
124. F
125. T
126. T
127. T
128. F
129. NS
130. F
131. F
132. T
133. T
134. T
135. T
136. NS
137. F
138. T
139. T
140. NS
141. D
142. E
143. B
144. B
145. D
146. T
147. F
148. F
149. F
150. T
151. T
152. T
153. F
154. T
155. F
156. T
157. F
158. T
159. F
160. T
161. T
162. T
163. T
164. F
165. T
166. T
167. T
168. F
169. F
170. T
171. T
172. T
173. T
174. T
175. F
176. T
177. T
178. T
179. F
180. T
181. T
182. T
183. T
184. F
185. T
186. D
187. B
188. D
189. C
190. B
191. T
192. T
193. F
194. T
195. F
196. F
197. T
198. T
199. F
200. F
201. F
202. F
203. F
204. F
205. T
206. F
207. T
208. T
209. T
210. T
211. T
212. T
213. F
214. F
215. T
216. T
217. T
218. T
219. F
220. T
221. F
222. T
223. F
224. F
225. T
226. T
227. F
228. T
229. T
230. F
231. D
232. D
233. D
234. A
235. B
236. F
237. T
238. F
239. F
240. F
241. T
242. T
243. F
Conn's tumours are usually small at diagnosis, due to endocrine effects.
244. T
245. T
246. F
247. T
248. F
249. T
250. F
Perirenal space is only around the kidney and adrenal.
251. F
252. T
253. T
254. F
255. F
Central calcifications.
256. F
257. T
258. F
259. T
260. T
261. F
262. T
263. T
264. T
265. F
266. T
267. F
268. T
269. F
270. F
271. F
272. T
273. T
274. T
275. T
276. B
277. B
278. D
279. C
280. E
281. F
282. T
283. F
SMA and IMA
284. T
285. T
286. T
287. F
288. T
289. T
290. F
291. F
292. NS
293. T
294. F
295. NS
296. T
297. F
298. T
299. F
300. F
301. T
302. T
303. F
304. F
305. T
306. T
307. T
308. F
309. F
310. T
311. F
Improve anticoagulation first.
312. F
Just need to be below it.
313. F
314. T
315. T
316. T
317. T
318. F
319. F
320. T
321. C
322. B
323. F
324. A
325. D
326. F
327. F
328. T
329. T
330. T
331. T
332. F
333. F
334. T
335. T
336. F
337. NS
Up to 8 weeks, ? pattern
338. F
latent virus (papova or JC) in setting of immunosuppression
339. T
340. F
progressive demyelination and adrenal insufficiency, 3-10 years, X-linked recessive.
341. T
342. T
343. T
344. F
345. T
346. F
cerebellum 65%, brain stem 20%, spinal cord 15%
347. T
348. T
349. T
350. F
351. F
352. F
extradural
353. T
354. T
355. T
356. T
357. T
358. F
Signal intensity similar to mucosa.
359. T
360. T
361. T
362. F
Retrobulbar fat 76%, extraocular muscle, 57%, optic nerve 38%.
363. T
364. T
365. T
366. D
367. B
368. B
369. A
370. E
371. F
372. T
373. T
374. F
375. F
376. F
377. F
378. T
379. T
380. F
381. F
Myocardium and mitochondria rich
382. T
383. T
384. F
385. F
Good indication
386. T
387. F
Just a perfusion study.
388. T
389. F
390. T
391. T
392. F
Efferent
393. F
Overnight except β blocker.
394. F
MAG3
395. F
396. F
Blocks uptake
397. T
398. T
399. T
400. T
401. T
402. F
403. F
404. F
405. T
406. T
407. F
408. T
409. F
410. T
411. B
412. A
413. D
414. D
415. A
416. F
Subglottic
417. F
Self limiting
418. T
419. F
25%
420. F
Not mentioned
421. F
28%
422. F
15%
423. F
less
424. T
425. F
> 50%
426. T
427. F
multiple
428. T
429. T
430. F
vice-versa
431. T
432. T
433. T
434. F
20%
435. F
436. T
437. T
438. T
439. F
Benign hamartoma
440. T
441. T
442. T
443. T
444. T
445. T
446. T
447. F
Look for underlying cause and complication.
448. T
449. T
450. T
451. T
452. T
453. F
Up to 3 months US better
454. T
455. T
456. E
457. E
458. A
459. C
460. C
461. T
462. F
463. T
464. T
465. F
20MB
466. T
467. F
468. T
469. F Stochastic
470. F Deterministic
471. F void
472. F phase
473. T
474. F reduces
475. F thinner
476. F improved
477 T
478. F lower
479. F same
480. F longer
481. F kVp
482. F much less
483. F PE
484. T
485. F 4
486. T
487. T
488. T
489. T
490. F decreased or same with reciprocating
491. F
492. T
493. F
494. F
495. T
496. F
497. T Line focus principle
498. F In the anode cathode axis
499. T ? 0.3mm
500. F
501. B
502. C
503. E
504. A
505. D
506. F Caudate
507. F Medial segment of left, superior aspect
508. T
509. T
510. T
511. T
512. F Not produced by kidneys early on
513. F >4
514. T
515. F Numerous small cysts, hyperechoic
516. T
517. T
518. T
519. F ectopic
520. F most accurate
521. T
522. F
523. T
524. T
525. F
526. T
527. T
528. F hypoechoic
529. T
530. F
531. F Much higher
532. T
533. F inguinal
534. F
535. T
536. F can have venous occlusion first
537. F
538. T
539. T
540. F
541. T
542. F
543. F
544. T
545. T